Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
108.06
(
1.38%
)
Bitcoin
71,004.70
(
-0.33%
)
News Focus
News Focus

Replies to post #90032 on Biotech Values

Replies to #90032 on Biotech Values
icon url

DewDiligence

02/02/10 1:02 PM

#90033 RE: dewophile #90032

Agree on all counts—a very long half-life is not a desirable attribute for an HCV drug that's presumably vying for inclusion in a combination pill.